MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
A new study shows that in medulloblastoma, a malignant brain tumor of children, microRNA-218 is especially low. The article also shows that adding microRNA-218 to neural stem cells engineered to develop medulloblastoma decreases the development of the cancer.View Source
